Phase Holographic Imaging PHI
1,35
SEK
+4,65 %
Mindre end 1K følgere
PHI
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Ownership
Investor consensus
+4,65%
+1,5%
+12,97%
-17,68%
-32,5%
-83,42%
-74,14%
-95,34%
-90,49%
PHI is active in medical technology and develops both hardware and software for quantitative analysis of living cell cultures. The HoloMonitor® products are based on non-invasive QPI technology that collects data on cell quality and are sold globally through distributors with a focus on preclinical cancer research, stem cell research and drug development. Going forward, PHI focuses on developing its products for the clinical market and in regenerative medicine. PHI has offices in Lund, Boston, and Winston-Salem.
Læs mereMarkedsværdi
85,12 mio. SEK
Aktieomsætning
24,67 t SEK
Omsætning
10,51 mio.
EBIT %
-161,18 %
P/E
-
Udbytteafkast, %
-
Finanskalender
26.6
2025
Årsrapport '25